Administrative Core

Cobre第一阶段申请的主要目的是“俄克拉荷马州细胞代谢研究中心” (CMRO)，“是在俄克拉荷马州医学研究中心建立一个卓越的细胞代谢研究中心 基金会(OMRF)。细胞新陈代谢是生物医学研究进展最快的领域之一；然而，它 在俄克拉何马州还没有充分融入。为了解决这一未得到满足的需求，Cobre将提供关键的 有机会统一OMRF的新陈代谢相关资源和专业知识，支持五名新招聘的初级员工 教职员工，并促进增加细胞代谢研究和多学科科学互动 俄克拉荷马州。我们的目标是建立一个公认的细胞代谢研究的卓越中心。在支持中 在这些目标中，行政核心将提供集中管理并发挥协调作用 通过五个目标提供资源：1)为科布雷提供中央管理和后勤支持；2)提供 指导项目负责人，协助他们过渡到稳定的独立性；3)管理试点 项目计划；4)促进多学科方法研究眼镜蛇及其相互作用 调查人员；以及5)提供财务管理，确保遵守监管问题，并促进数据 分享策略。行政核心将具体确保方便地使用尚未完成的核心设施 以及在其他地方很难复制的支持网络。这只科布雷将会有一个持久的 对俄克拉荷马州生物医学研究的影响。

The primary purpose of this COBRE Phase I application, “Center for Cellular Metabolism Research in Oklahoma (CMRO),” is to establish a center of cellular metabolism research excellence at the Oklahoma Medical Research Foundation (OMRF). Cellular metabolism is one of the fastest moving areas of biomedical research; however, it has not been sufficiently integrated in Oklahoma. To address this unmet need, this COBRE will offer a critical opportunity to unify OMRF’s metabolism-related resources and expertise to support five newly recruited junior faculty and to foster increased cellular metabolism research and multidisciplinary scientific interactions overall in Oklahoma. Our goal is to establish a recognized center of excellence in cellular metabolism research. In support of these goals, the Administrative Core will provide centralized management and serve as the coordinating resource through five Aims: 1) Provide central management and logistical support for the COBRE; 2) Provide mentoring for the Project Leaders, and assist with their transition to stable independence; 3) Administer the Pilot Project program; 4) Promote multidisciplinary approaches to the research of and interactions among the COBRE investigators; and 5) Provide fiscal management, ensure compliance with regulatory issues, and promote data sharing strategies. The Administrative Core will specifically ensure easy access to outstanding Core facilities and a network of support that would be difficult to replicate elsewhere. This COBRE will have a long-lasting impact on biomedical research in Oklahoma.